Stockreport

Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study

Notable Labs, Ltd. - Ordinary Shares  (NTBL) 
PDF FOSTER CITY, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable”, “Notable Labs” or the “Company”), a clinical-stage precision oncol [Read more]